Researcher ICON Sued by Investor Over Revenue Miss Stock Dive
Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology ...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages ICON plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICLR
NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Rosen Law Firm PAWHY: Rosen Law Firm, a global investor rights law firm, announces the ...
Lost Money on ICON Public Limited Company (ICLR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want ...
ICLR stock touches 52-week low at $183.31 amid market challenges
ICON Plc 's stock (NASDAQ:ICLR) has reached a 52-week low, dipping to $183.31, as the company navigates through a turbulent market environment. With a market capitalization of $15.19 billion and a P/E ...
TMCnet1d
Deadline Approaching: ICON plc (ICLR) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased ICON plc ("ICON" or the ...
Hosted on MSN1mon
ICON Public Limited Company (ICLR) Slid on Drop in Biotechnology Funding
"ICON Public Limited Company (NASDAQ:ICLR): The stock pulled back on news that biotechnology funding has dropped, albeit from very strong growth levels. We continue to believe the company is a ...
TMCnet2d
Law Offices of Frank R. Cruz Encourages ICON plc (ICLR) Investors To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased ICON plc ("ICON" or the "Company") (NASDAQ: ICLR) ordinary shares between ...